Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 2 |
2019 | 1 |
2022 | 3 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
NQO1*2 polymorphism predicts overall survival in MDS patients.
Br J Haematol. 2019 Jan;184(2):305-308. doi: 10.1111/bjh.15088. Epub 2018 Jan 24.
Br J Haematol. 2019.
PMID: 29363755
Free article.
No abstract available.
Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways.
Minařík L, Pimková K, Kokavec J, Schaffartziková A, Vellieux F, Kulvait V, Daumová L, Dusilková N, Jonášová A, Vargová KS, Králová Viziová P, Sedláček R, Zemanová Z, Stopka T.
Minařík L, et al.
Cells. 2022 Jan 11;11(2):223. doi: 10.3390/cells11020223.
Cells. 2022.
PMID: 35053339
Free PMC article.
Item in Clipboard
Combined Approach to Leukemic Differentiation Using Transcription Factor PU.1-Enhancing Agents.
Bašová P, Paszeková H, Minařík L, Dluhošová M, Burda P, Stopka T.
Bašová P, et al. Among authors: minarik l.
Int J Mol Sci. 2022 Jun 16;23(12):6729. doi: 10.3390/ijms23126729.
Int J Mol Sci. 2022.
PMID: 35743167
Free PMC article.
Item in Clipboard
G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial.
Stopka T, Minařík L, Dusilková N, Pešta M, Kulvait V, Špaček M, Zemanová Z, Kalousová M, Jonášová A.
Stopka T, et al. Among authors: minarik l.
Blood Cancer J. 2022 Jul 7;12(7):105. doi: 10.1038/s41408-022-00698-2.
Blood Cancer J. 2022.
PMID: 35798720
Free PMC article.
Clinical Trial.
Item in Clipboard
Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients).
Jonasova A, Neuwirtova R, Polackova H, Siskova M, Stopka T, Cmunt E, Belickova M, Moudra A, Minarik L, Fuchs O, Michalova K, Zemanova Z.
Jonasova A, et al. Among authors: minarik l.
Leuk Res. 2018 Jun;69:12-17. doi: 10.1016/j.leukres.2018.03.015. Epub 2018 Mar 27.
Leuk Res. 2018.
PMID: 29614393
Item in Clipboard
Somatic mutation dynamics in MDS patients treated with azacitidine indicate clonal selection in patients-responders.
Polgarova K, Vargova K, Kulvait V, Dusilkova N, Minarik L, Zemanova Z, Pesta M, Jonasova A, Stopka T.
Polgarova K, et al. Among authors: minarik l.
Oncotarget. 2017 Dec 6;8(67):111966-111978. doi: 10.18632/oncotarget.22957. eCollection 2017 Dec 19.
Oncotarget. 2017.
PMID: 29340104
Free PMC article.
Item in Clipboard
Cite
Cite